Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Amniotic Membrane AND Amniotic Fluid | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Ambulatory AND Outpatient Cardiac Hemodynamic Monitoring OF Heart Failure | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Ambulatory Blood Pressure Monitoring Abpm | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Ambulance Services Ground Transportation | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Ambulance Services AIR AND Water Transportation | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Alpha1 Proteinase Inhibitor Infusions | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Allogeneic Hematopoietic Cell Transplantation FOR Myelodysplastic Syndromes AND Myeloproliferative Neoplasms | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Allogeneic Hematopoietic Cell Transplantation FOR Genetic Diseases AND Acquired Anemia | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Allergy Skin Testing | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Allergy Immunotherapy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Alglucosidase Alfa Lumizyme ME | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Alglucosidase Alfa Lumizyme | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Alemtuzumab Lemtrada | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Agalsidase Beta Fabrazyme ME | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Agalsidase Beta Fabrazyme | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Adoptive Immunotherapy | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | ADO Trastuzumab Emtansine Kadcyla | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Acupuncture FOR Pain Management Nausea AND Vomiting AND Opioid Dependence | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Actinic Keratosis | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Arthrex Bovine Collagen | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Radiofrequency Ablation OF Miscellaneous Solid Tumors Excluding Liver Tumors | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Radiofrequency Ablation RFA AND Cryosurgery OF Primary OR Metastatic Liver Tumors | New policy |
| Aug 2, 2026 | Blue Cross Blue Shield of North Dakota | Abatacept Orencia | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Zurzuvae (zuranolone) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ztalmy (ganaxolone) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Zolgensma (onasemnogene abeparvovec) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Zoladex (goserelin) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Zevaskyn (prademagene zamikeracel) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Yeztugo (lenacapavir) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ycanth (cantharidin) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Xyrem (sodium oxybate) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Xolair (omalizumab) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Xiaflex (collagenase clostridium histolyticum) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Wireless Pressure Sensors in Endovascular Aneurysm Repair | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Wireless Capsule Endoscopy for Gastrointestinal (GI) Disorders | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Wide Abdominoplasty Rectus Plication (WARP) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Whole Gland Cryoablation of Prostate Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Whole Body Dual X-Ray Absorptiometry to Determine Body Composition | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Whole Body Computed Tomography Scan as a Screening Test | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Wearable Cardioverter Defibrillators | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Vyvanse (lisdexamfetamine dimesylate) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Vraylar (cariprazine) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Voydeya (danicopan) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Vitamin D Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Viscocanalostomy and Canaloplasty | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Viberzi (eluxadoline) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Vertical Expandable Prosthetic Titanium Rib | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Vertebral Fracture Assessment with Densitometry or Biomechanical Computed Tomography | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Vertebral Axial Decompression | New policy |